Business

RAD Approval for Phase 1 Therapeutic Trial of RAD 402

RAD Approval for Phase 1 Therapeutic Trial of RAD 402

Radiopharm Theranostics LimitedNovember 17, 20253
RAD Approval for Phase 1 Therapeutic Trial of RAD 402

About this update from Radiopharm Theranostics Limited

Radiopharm Theranostics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Radiopharm Theranostics Limited

More from Radiopharm Theranostics Limited

All Radiopharm Theranostics Limited news →